James Swinehart, MD
Dermatology · Denver, CONPI 1073624748
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $494 and has fallen 76.5% since, to $116 in 2025. That places this record below the midpoint for dermatology clinicians in CO, where the typical reported total is $1,877.
Across 57 payments — averaging $33.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$401
- Johnson & Johnson$395
- AbbVie$306
- Lilly USA, LLC$198
- Novartis$114
- Solta Medical, A Division Of Bausch Health US, LLC$109
- plus $395 from 6 others
Across 147 payments — averaging $6319.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$358K
- Aclaris Therapeutics, Inc.$279K
- Incyte Corporation$194K
- Vanda Pharmaceuticals Inc.$88K
- Merck$7K
- LEO Pharma AS$3K
What the payments were for
- Food & beverage$1,917100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 17 | $401 |
| Johnson & Johnson | 14 | $395 |
| AbbVie | 5 | $306 |
| Lilly USA, LLC | 4 | $198 |
| Novartis | 5 | $114 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $109 |
| Galderma Laboratories, L.p. | 1 | $99 |
| LEO Pharma Inc. | 2 | $98 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Sanofi | 2 | $57 |
| Pfizer | 3 | $55 |
| Incyte Corporation | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,917 in reported general payments places this provider in the 50th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 12 | $104,178 |
| Fluocinonide | 41 | $2,387 |
| Mupirocin | 227 | $1,889 |
| Azithromycin | 281 | $1,155 |
| Ketoconazole | 68 | $849 |
| Ciclopirox | 13 | $765 |
| Cephalexin | 23 | $523 |
| Terbinafine Hcl | 24 | $318 |
| Clindamycin Phosphate | 12 | $290 |
| Sulfasalazine | 11 | $284 |
| Clobetasol Propionate | 14 | $233 |
| Doxycycline Hyclate | 15 | $190 |
| Methylprednisolone | 16 | $132 |
| Hydroxyzine Hcl | 16 | $55 |
| Triamcinolone Acetonide | 16 | $42 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Denver
- Drew TaylorDenver$135K
- Adrienne StewartDenver$102K
- Elizabeth ShurnasDenver$13K
- Carl DemidovichDenver$13K
- Elizabeth RobinsonDenver$11K
- Caroline HaganDenver$8K
- Lindsey BroussardDenver$7K
- Catherine CarreteroDenver$7K
- Channing HoodDenver$7K
- Marcjonathan SerotaLittleton$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.